EBS
Emergent Biosolutions Inc
7.00$
+4.0%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +21.0% | -0.1% | +14.8% | +39.5% | +41.4% | +42.6% | +12.4% | -37.0% | -6.1% | -0.5% | -28.8% | |
| – | +4.9% | +12.5% | +13.6% | +66.6% | +34.8% | +14.7% | +37.3% | -34.3% | +7.0% | -3.1% | -41.3% | |
| – | +37.8% | -10.2% | +15.8% | +13.0% | +50.8% | +78.7% | -8.1% | -40.4% | -23.9% | +4.3% | -6.6% | |
| – | +13.8% | -10.3% | -8.9% | +46.6% | +58.4% | +5.2% | -1.1% | -19.9% | -40.8% | -36.5% | -23.9% | |
| – | +20.9% | -3.2% | -0.1% | +41.1% | +35.1% | +10.9% | +14.6% | -2.1% | +9.6% | -17.4% | -39.6% | |
| – | +20.6% | +6.4% | +14.4% | +44.8% | +60.0% | +15.1% | +6.4% | +42.3% | +69.0% | -55.4% | -50.3% | |
| – | +58.7% | -25.4% | +17.8% | -27.8% | +27.1% | +284.3% | -22.1% | -149.8% | – | – | – | |
| – | -20.8% | +16.8% | -13.5% | +50.2% | +287.9% | -18.5% | +10.2% | +8.1% | +135.7% | -19.2% | -16.5% | |
| – | +61.2% | -26.9% | +19.6% | -31.3% | -5.0% | +432.2% | -26.4% | -172.2% | – | – | – | |
| – | +48.0% | -17.2% | -1.9% | -47.8% | +21.8% | +363.3% | -21.1% | -108.8% | – | +62.8% | -36.7% | |
| – | +71.1% | -17.6% | +59.5% | -24.1% | -13.1% | +461.1% | -28.2% | -196.4% | – | – | – | |
| – | +53.5% | -28.8% | +31.5% | -11.2% | +66.9% | +135.3% | -17.2% | -96.9% | -399.4% | – | +350.2% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.